Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed the first synthetic compound that can reverse the effects of a serious metabolic condition known as fatty liver disease. True to its name, the disease involves an abnormal buildup of fat in the liver.
Recent PostsSaturday, January 14, 2017
The University of South Florida College of Engineering and the USF Health Morsani College of Medicine have established the Department of Medical Engineering, a unique transdisciplinary concept that will combine the related aspects of engineering and medicine while providing access to real-world health care environments for education and research. ..Read More ⇒Thursday, January 12, 2017
Florida-based Flight Level Engineering has become the first company to join the Customized Business Acceleration Program at the John Mica Engineering and Aerospace Innovation Complex (MicaPlex) at Embry-Riddle Research Park in Daytona Beach. ..Read More ⇒Thursday, January 12, 2017
According to a 2015 report by the NIH’s National Institute on Aging, in the last five years of life, total health care spending for people with dementia was more than a quarter of a million dollars per person, 57 percent more than the costs associated with death from other diseases, including cancer and heart disease. ..Read More ⇒Thursday, January 12, 2017
Immunotherapy is a fast growing area of cancer research. It involves developing therapies that use a patient’s own immune system to fight and kill cancer. Moffitt Cancer Center is working on a new vaccine that would help early-stage breast cancer patients who have HER2 positive disease. ..Read More ⇒Wednesday, January 11, 2017
Graft-versus-host-disease (GVHD) is the leading cause of non-relapse associated death in patients who receive stem cell transplants. In a new study published as the cover story in Science Translational Medicine, Moffitt Cancer Center researchers show that a novel treatment can effectively inhibit the development of GVHD in mice and maintain the infection- and tumor-fighting capabilities of the immune system. ..Read More ⇒
TagsGrowFL accolades research policy Florida Hospital VGTI health gender business animals Florida State University IHMC Scripps Research Institute University of Florida bioscience biochemistry accounting neuroscience biotechnology Draper Nanotheraputics University of Central Florida FAMU aerospace marine HIV/AIDS society/culture Banyan Biomarkers computer science Mayo Clinic agriculture nanotechnology Moffitt Cancer Center aging ecology magnets biomedical green technology Torrey Pines Institute environment robotics astronomy materials science innovation clean energy partnerships conference / event health care grants children photonics technology BioFlorida Nova Southeastern Univ. physics economy awards Jackson Lab commercialization consumers stem cell Florida Gulf Coast Univ. medical University of Miami Max Planck Florida Atlantic University Florida Power & Light Florida Trend University of North Florida Enterprise Florida policy FL Institute for Commercialization of Public Research energy Sanford-Burnham education ICFO sciences Univeristy of South Florida Embry-Riddle engineering Florida Institute of Technology research AGTC accreditation University of West Florida cancer Florida International Univ. AxoGen sustainability